Dynavax Technologies Corp DVAX

Healthcare Drug Manufacturers - Specialty & Generic

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally. The company offers HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in adults aged 18 years and older; and CpG 1018, the adjuvant used in HEPLISAV-B. It also develops rF1V, a plague vaccine candidate in Phase 2 clinical trial; and Z-1018, an investigational vaccine candidate in Phase 1/2 clinical trial for the prevention of shingles in adults aged 50 years and older, as well as HEPLISAV-B for adults on hemodialysis. The company sells its products to hospitals and clinics, integrated delivery networks, public health clinics and prisons, the Department of Defense, the Department of Veterans Affairs, and retail pharmacies through wholesalers and specialty distributors. It has a collaboration agreement with the U.S. Department of Defense; Coalition for Ep...

NDAQ:DVAX - Post by User

Dynavax Technologies Corp

<< Previous

Bullboard Posts

Next >>

(3)
•••

Post by wmcveyon Dec 11, 2020 12:04pm

289 Views

Post# 32088691

Hep-b approval and Corona vaccine trial updates imminent

More than doubling of the Hep-B vaccine market, Dynavax's primary revenue source, looks very likely: https://www.prnewswire.com/news-releases/european-chmp-adopts-positive-opinion-for-heplisav-b-dynavaxs-two-dose-adult-hepatitis-b-adjuvanted-vaccine-301190681.html

This, alongside news from the multiple Covid trials Dynavax contributed an adjuvant for, bodes well for a doubling of the stock once again. $5 to $10, as we saw in the summer, looks likely to me within the next quarter, depending on Covid results. This could be especially important in light of reported setbacks my vaccine giant GSK. Door is open build on success from Moderna and Pfizer.

<< Previous

Bullboard Posts

Next >>

A compelling Nevada gold story as the Walker Lane reasserts its importance